ABSTRACT:
For thousands of years, people have prized medicinal plants as a rich source of therapeutic compounds for the treatment of a wide range of illnesses. Today, a sizable portion of the population suffers from kidney stones and urinary calculi. Stone illness has increased in incidence due to changes in lifestyle. The four main types of stones that form in the kidneysare calcium stones (75 to 85%), struvite stones (2 to 15%), uric acid stones (6 to 10%) and cystine stones (1 to 2%). The most common stone recorded in India is Calcium oxalate Kidney stones. Surgical treatment of the kidney stone is expensive and may result into reoccurance also. Since Herbal Plants are safer, more efficient, more acceptable culturallyand have fewer side effects than produced pharmaceuticals. Medicinal herbs have been used for treatment of kidney stone for millennia. Patients are recommended to follow a low-fat diet and take herbal remedies in addition to fibre from naturally occurring plants. Antiurolithiatic Herbs are used to treat Kidney Stones. The purpose of this article is to review the different types, diagnostic methods, ancient treatment of kidney stone and to emphasize the use of medicinal herbs for the treatment for Kidney Stones.
Cite this article:
Harshad Movaliya, Mital Gohel. An Overview on Kidney Stone Based on Medicinal Plants. Research Journal of Pharmacognosy and Phytochemistry. 2024; 16(2):133-7. doi: 10.52711/0975-4385.2024.00026
Cite(Electronic):
Harshad Movaliya, Mital Gohel. An Overview on Kidney Stone Based on Medicinal Plants. Research Journal of Pharmacognosy and Phytochemistry. 2024; 16(2):133-7. doi: 10.52711/0975-4385.2024.00026 Available on: https://rjpponline.org/AbstractView.aspx?PID=2024-16-2-15
REFERENCE:
1. Kirkali Z. Rasooly R. Star RA. Rodgers GP. Urinary Stone Disease: Progress, Status, and Needs. Urology. 2015; 86(4): 651-3. doi: 10.1016/j.urology.2015.07.006.
2. Eknoyan G. History of urolithiasis: Clinical Reviews in Bone and mineral metabolism. 2004; 2(3): 177–185.
3. Moe OW. Kidney stones: pathophysiology and medical management. The Lancet. 2006; 367(9507): 333–344. doi: 10.1016/s0140-6736(06)68071-9.
4. Romero V. Akpinar H. Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Reviews in Urology. 2010; 12(2-3): 86–96.
5. Edvardsson VO. Indridason OS. Haraldsson GK. Jartansson O. Palsson R. Temporal trends in the incidence of kidney stone disease. Kidney International. 2013; 83(1): 146–152. doi: 10.1038/ki.2012.320.
6. Chhiber N. Sharma M. Kaur T. Singla S. Mineralization in health and mechanism of kidney stone formation. International Journal of Pharmaceutical Science Invention. 2014; 3:25–31.
7. Barnela SR. Soni SS. Saboo SS. Bhansali AS. Medical management of renal stone. Indian J Endocrinol Metab. 2012; 16(2): 236-9. doi: 10.4103/2230-8210.93741.
8. Evan AP. Worcester EM. Coe FL. Williams J. Lingeman JE. Mechanisms of human kidney stone formation. Urolithiasis. 2015; 43: 19-23. doi: 10.1007/s00240-014-0701-0.
9. Coll DM. Varanelli MJ. Smith RC. Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT. AJR Am J Roentgenol. 2002; 178(1): 101-3. doi: 10.2214/ajr.178.1.1780101.
10. López M. Hoppe B. History, epidemiology and regional diversities of urolithiasis. Pediatric Nephrology. 2010; 25(1): 49-59. doi: 10.1007/s00467-008-0960-5.
11. Kasote D. Jagtap S. Thapa D. Khyade M. Russell R. Herbal remedies for urinary stones used in India and China: A review. Journal of Ethnopharmacology. 2017; 203: 55-68.
12. Sandhya A. Sandhya G. Sreedevi V. Deepika P. Hema Prasad M. Kidney stone disease: etiology and evaluation. International Journal of Applied Biology and Pharmaceutical Technology. 2010; 1(1): 175-82.
13. Stamatelou KK. Francis ME. Jones CA. Time trends in the reported prevalence of kidney stones in the UnitedStates. KidneyInt. 2003; 63: 1817–23.
14. Gohel MK. Patel CN. Pandya SS. A brief review on pathophysiology, contributing factors and treatment of kidney stones. World Journal of Pharmacy and Pharmaceutical Sciences. 2022; 11(9): 348-365.
15. Semins MJ. Matlaga BR. Medical evaluation and management of urolithiasis. Ther Adv Urol. 2010; 2(1): 3-9. doi: 10.1177/1756287210369121.
16. Pak CYC. Peterson R. Poindexter JR. Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis. J Urol. 2001; 165: 378–381.
17. Parks JH. Goldfisher E. Asplin JR. Coe FL. A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol. 2002; 167:1607–1612.
18. Gücük A. Uyetürk U. Usefulness of hounsfield unit and density in the assessment and treatment of urinary stones. World J Nephrol. 2014; 3(4): 282-6.
19. Mukerjee T. Bhalla N. Singh G. Jain HC. Herbal drugs for urinary stones. Indian Drugs. 1984; 224- 228.
20. Bahu CP. Seshadri RT. In Advances in Research in Indian Medicine (B.H.U.). 1970; 77-78.
21. Chunekar KC. Vanasuhadi Anushandhan Durshika. Chaukhamba Vidyabhawan, Varanasi. 1969; 5thed:pp.13.
22. Bhandari CR. Basu BD. Vanasuhadi Chandrodaya. Gyan Mandir, Bhanupura publisher, Indor. 1948; 2nd ed: 48.
23. Kirtikar KR. Basu BD. Herbal plants in urolithiasis. In Indian Medicinal Plants. Lalit Mohan Basu Publisher, Allahabad. 1933; 2nd ed: 56.
24. Dush B. Kashyap L. Herbal plants in Kidney stone. In Materia Medica of Ayurveda. Concept Publishing Co, New Delhi. 1979; 89.
25. Bhisa KL. Kidney stone.English Translation of Sushruta Samhita. 1981; 21:106.
26. Shah CS. Shan N. Mody KD.Drugs used in urolithiasis. Q. J. Crude Drug Research. 1972; 12:1882-93.
27. Dubey SD. Singh RS. Sen SP. Kumar N.Disease of kidney stone and urinary tract. Med. Surg. 1982; 22:9-12.
28. Shrivastava JG. Herbal plants used in stone. Q. J. Crude Drug Research. 1971; 11:1683-89.
29. Legal status of traditional medicine and complementary/alternative medicine: a worldwide review. World Health Organization. 2001. Available on: https://apps.who.int/iris/handle/10665/42452
30. Sridevi V. Rajya Lakshmi I. Sanjeeva Rao I. Urolithiasis (Mutrashmari). Scientific basis for Ayurvedic Therapies.Edited by Lakshmi Chandra Mishra. Boca Raton. CRC Press LLC. 2004; 536-548.
31. Pullaiah P. Narasimha Kumar GV. Narasimha Kumar GV. Vineela Ruth. Madhuri P. Pushpa Kumari B.Ranganayakulu D. Dhanunjaya S. Supplementation of Ethanolic Extract of Abutilon indicum (L) Sweet Prevents Urolithiasis in Experimental Rats. International Journal of Pharmacometrics and Integrated Biosciences. 2015; 1(1):7-13.
32. Chauhan PN. Kumar D.Kasana MS. Medicinal Plants of Muzaffarnagar district used in treatment of Urinary tract and Kidney stones. Indian Journal of Traditional Knowledge. 2009; 8(2):191-195.
33. MohdAzaz Khan. Debasish Pradhan. Antiurolithic activity of Ageratum conzoides extract in rats. Pharmacologyonline. 2011; 3: 953-958.
34. Sharma N. Tanwer BS. Vijayvergia R. Study of medicinal plants in Aravali regions of Rajasthan for treatment of kidney stone and urinary tract troubles. International Journal of PharmTech Research. 2011; 3(1):110-113.
35. Soundararajan P. Mahesh R. Ramesh T. Hazeena Begum V. Effect of Aerva Lanata on calcium oxalate urolithiasis in rats. Indian Journal of Experimental Biology. 2006; 44:981-986.
36. Ananta Teepa KS. Kokilavani R. Balakrishnan A. Gurusamy K. Effect of ethanolic fruit extract of Pedalium murex Linn in ethylene glycol induced urolithiasis in male wistar albino rats. Ancient Science Life. 2010; 29:29-34.
37. Satish H. Raman D. Kshama D. Shivananda BG. Shridhar KA. Study the relative effect of Spironolactone and different solvent extract of Tibulusterrestrison urolithiatic rats. Pharmacognosy Magazine. 2009; 5:83-9.
38. Sailaja BK. Bharathi KP. Protective effect of Tridax procumbens on calcium oxalate urolithiasis and oxidative stress. An International Journal of Advances in Pharmaceutical Sciences. 2011; 2(1):1-6.